• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受癌症化疗患者使用的止吐药:Δ⁹-四氢大麻酚与丙氯拉嗪的随机对照比较

Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.

作者信息

Sallan S E, Cronin C, Zelen M, Zinberg N E

出版信息

N Engl J Med. 1980 Jan 17;302(3):135-8. doi: 10.1056/NEJM198001173020302.

DOI:10.1056/NEJM198001173020302
PMID:6985702
Abstract

Delta-9-tetrahydrocannabinol (THC) is an effective antiemetic as compared with placebos in patients receiving chemotherapy for cancer. In this study we compared THC with prochlorperazine (compazine) in a randomized, double-blind, crossover trial with patients who had failed to benefit from standard antiemetic therapy. Regardless of the emetic activity of the chemotherapeutic agents, there were more complete responses to THC courses (in 36 of 79 courses) than to prochlorperazine (in 16 of 78 courses). Of 25 patients who were treated with both drugs and who expressed a preference, 20 preferred THC (P = 0.005). Among patients under 20 years of age there was a higher proportion of complete responses to THC courses (15 of 20) than among older patients (21 of 59 courses; P = 0.004). Increased food intake occurred more frequently with THC (P = 0.008) and was associated with the presence of a "high." Of 36 THC courses resulting in complete antiemetic responses, 32 were associated with a high. We conclude that THC is an effective antiemetic in many patients who receive chemotherapy for cancer and for whom other antiemetics are ineffective. (N Engl J Med 302:135--138, 1980).

摘要

与安慰剂相比,Δ-9-四氢大麻酚(THC)对接受癌症化疗的患者是一种有效的止吐药。在本研究中,我们在一项随机、双盲、交叉试验中,将THC与丙氯拉嗪(康帕嗪)进行比较,受试患者为那些未能从标准止吐疗法中获益的患者。无论化疗药物的致吐活性如何,THC疗程的完全缓解率(79个疗程中有36个)高于丙氯拉嗪(78个疗程中有16个)。在同时接受两种药物治疗并表达了偏好的25例患者中,20例更喜欢THC(P = 0.005)。在20岁以下的患者中,THC疗程的完全缓解率(20个疗程中有15个)高于老年患者(59个疗程中有21个;P = 0.004)。THC使食物摄入量增加的情况更频繁(P = 0.008),且与“兴奋感”的出现有关。在36个产生完全止吐反应的THC疗程中,32个与兴奋感有关。我们得出结论,对于许多接受癌症化疗且其他止吐药无效的患者,THC是一种有效的止吐药。(《新英格兰医学杂志》302:135 - 138, 1980)

相似文献

1
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.接受癌症化疗患者使用的止吐药:Δ⁹-四氢大麻酚与丙氯拉嗪的随机对照比较
N Engl J Med. 1980 Jan 17;302(3):135-8. doi: 10.1056/NEJM198001173020302.
2
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.δ-9-四氢大麻酚改善癌症化疗引起的恶心和呕吐。
Med J Aust. 1979 Dec 15;2(12):657-9.
3
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.Δ⁹-四氢大麻酚对接受癌症化疗患者的止吐作用。
N Engl J Med. 1975 Oct 16;293(16):795-7. doi: 10.1056/NEJM197510162931603.
4
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.奈必洛尔与丙氯拉嗪用于控制儿童癌症化疗引起的呕吐:一项双盲交叉试验。
Pediatrics. 1987 Jun;79(6):946-52.
5
Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.地塞米松的止吐疗效。在接受癌症化疗的患者中与丙氯拉嗪进行的随机、双盲、交叉研究。
N Engl J Med. 1984 Aug 30;311(9):549-52. doi: 10.1056/NEJM198408303110901.
6
Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.纳布啡酮与氯丙嗪对化疗引起呕吐的止吐作用的双盲比较。
Cancer Treat Rep. 1980 Feb-Mar;64(2-3):219-24.
7
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.纳布啡酮在接受癌症化疗患者中作为止吐药优于丙氯拉嗪。
N Engl J Med. 1979 Jun 7;300(23):1295-7. doi: 10.1056/NEJM197906073002302.
8
Delta-9-tetrahydrocannabinol as an antiemetic.
Am J Hosp Pharm. 1981 May;38(5):639-46.
9
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Cancer Treat Rep. 1985 Jan;69(1):109-12.
10
Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Clin Pharm. 1984 Nov-Dec;3(6):618-21.

引用本文的文献

1
Cannabinoids for the prevention of chemotherapy-induced nausea and vomiting in oncological therapy: a systematic review.大麻素类药物在肿瘤治疗中预防化疗引起的恶心和呕吐:一项系统评价
J Cancer Surviv. 2025 Aug 12. doi: 10.1007/s11764-025-01876-4.
2
Cannabinoids for Medical Purposes in Children: A Living Systematic Review.儿童医用大麻素:一项实时系统评价
Acta Paediatr. 2025 Sep;114(9):2148-2159. doi: 10.1111/apa.70140. Epub 2025 May 28.
3
Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review.
癌症患者使用大麻类产品相关的不良事件:一项系统的范围综述。
Support Care Cancer. 2024 Dec 18;33(1):40. doi: 10.1007/s00520-024-09087-w.
4
The use of cannabinoids in palliating cancer-related symptoms: a narrative review.大麻素在缓解癌症相关症状中的应用:一项叙述性综述。
Proc (Bayl Univ Med Cent). 2024 Feb 8;37(2):288-294. doi: 10.1080/08998280.2023.2301241. eCollection 2024.
5
Tetrahydrocannabinols: potential cannabimimetic agents for cancer therapy.四氢大麻酚:用于癌症治疗的潜在大麻模拟剂。
Cancer Metastasis Rev. 2023 Sep;42(3):823-845. doi: 10.1007/s10555-023-10078-2. Epub 2023 Jan 25.
6
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.医用大麻素:基于药理学的系统评价和荟萃分析,涵盖所有相关医学适应证。
BMC Med. 2022 Aug 19;20(1):259. doi: 10.1186/s12916-022-02459-1.
7
Characteristics of adults with a medical cannabis license, reasons for use, and perceptions of benefit following medical cannabis legalization in Oklahoma.俄克拉荷马州医用大麻合法化后,持有医用大麻许可证的成年人的特征、使用原因及对益处的认知
Prev Med Rep. 2022 Mar 22;27:101777. doi: 10.1016/j.pmedr.2022.101777. eCollection 2022 Jun.
8
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes.老年患者化疗所致恶心和呕吐的预防:优化结局。
Drugs Aging. 2022 Jan;39(1):1-21. doi: 10.1007/s40266-021-00909-8. Epub 2021 Dec 9.
9
Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.大麻素系统在癌症中的利弊:聚焦血液系统恶性肿瘤。
Molecules. 2021 Jun 24;26(13):3866. doi: 10.3390/molecules26133866.
10
The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology.大麻素作为儿科肿瘤学中抗癌剂的作用。
Cancers (Basel). 2021 Jan 5;13(1):157. doi: 10.3390/cancers13010157.